Coronary Artery Spasm in Memory of Prof

Professor Maseri pioneered the research and treatment of coronary vasomotion abnormalities represented by coronary vasospasm and coronary microvascular dysfunction (CMD). These mechanisms can cause myocardial ischaemia even in the absence of obstructive coronary artery disease, and have been appreciated as an important aetiology and therapeutic target with major clinical implications in patients with ischaemia with non-obstructive coronary artery disease (INOCA). Coronary microvascular spasm is one of the key mechanisms responsible for myocardial ischaemia in patients with INOCA. Comprehensive assessment of coronary vasomotor reactivity by invasive functional coronary angiography or interventional diagnostic procedure is recommended to identify the underlying mechanisms of myocardial ischaemia and to tailor the best treatment and management based on the endotype of INOCA. This review highlights the pioneering works of Professor Maseri and contemporary research on coronary vasospasm and CMD with reference to endothelial dysfunction, Rho-kinase activation and inflammation.

[1]  K. Channon,et al.  Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership , 2022, Heart.

[2]  C. Berry,et al.  Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis , 2022, Journal of the American Heart Association.

[3]  H. Shimokawa,et al.  Isolated cardiac sarcoidosis associated with coronary vasomotion abnormalities: a case report , 2022, European heart journal. Case reports.

[4]  Tomoki Sakaue,et al.  Intracoronary ergonovine testing among 505 consecutive Japanese patients with angina-like chest pain and unobstructed coronary artery disease , 2022, Heart and Vessels.

[5]  P. Damman,et al.  Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm. , 2022, JACC. Cardiovascular interventions.

[6]  V. Fuster,et al.  A tribute to Attilio Maseri. , 2021, European heart journal.

[7]  H. Shimokawa,et al.  Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm. , 2021, Journal of visualized experiments : JoVE.

[8]  G. Niccoli,et al.  Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. , 2021, Journal of the American College of Cardiology.

[9]  F. Crea,et al.  Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group , 2021, European heart journal.

[10]  T. Shindo,et al.  Prognostic Links Between OCT-Delineated Coronary Morphologies and Coronary Functional Abnormalities in Patients With INOCA. , 2021, JACC. Cardiovascular interventions.

[11]  H. Shimokawa,et al.  Pathophysiology and Diagnosis of Coronary Functional Abnormalities , 2021, European cardiology.

[12]  H. Shimokawa,et al.  Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction , 2021, European cardiology.

[13]  J. Kastrup,et al.  Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study. , 2020, European heart journal.

[14]  L. Lerman,et al.  Association of Coronary Microvascular Endothelial Dysfunction with Vulnerable Plaque Characteristics in Early Coronary Atherosclerosis. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[15]  Sanjiv J. Shah,et al.  Association of Coronary Microvascular Dysfunction with Heart Failure Hospitalizations and Mortality in Heart Failure with Preserved Ejection Fraction - a follow-up in the PROMIS-HFpEF study. , 2020, Journal of cardiac failure.

[16]  A. Baumbach,et al.  An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. , 2020, European heart journal.

[17]  U. Sechtem,et al.  Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries. , 2020, European heart journal. Acute cardiovascular care.

[18]  A. Chieffo,et al.  Gender-Related Differences in Clinical Presentation and Angiographic Findings in Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA): A Single-Center Observational Registry , 2020, International Journal of Angiology.

[19]  V. Murthy,et al.  Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta‐Analysis of Aggregate Data , 2020, Journal of the American Heart Association.

[20]  A. Quyyumi,et al.  Soluble Urokinase‐Type Plasminogen Activator Receptor and High‐Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease , 2020, Journal of the American Heart Association.

[21]  T. Shindo,et al.  Marked Impairment of Endothelium-Dependent Digital Vasodilatations in Patients With Microvascular Angina , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[22]  D. Holmes,et al.  Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003-2016. , 2020, JAMA network open.

[23]  T. Shindo,et al.  Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia. , 2019, International journal of cardiology.

[24]  S. Miyata,et al.  Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease. , 2019, Journal of the American College of Cardiology.

[25]  F. Crea,et al.  Clinical outcomes in patients with primary stable microvascular angina: is the Jury still out? , 2019, European heart journal. Quality of care & clinical outcomes.

[26]  U. Sechtem,et al.  Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA) , 2019, Clinical Research in Cardiology.

[27]  E. Prescott,et al.  Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. , 2018, European heart journal.

[28]  A. Quyyumi,et al.  Peripheral Microvascular Function Reflects Coronary Vascular Function. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Christopher J. Rush,et al.  Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.

[30]  Gabriel A. Koepp,et al.  Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial , 2018, JAMA.

[31]  R. de Caterina,et al.  Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis , 2018, European heart journal.

[32]  T. Shindo,et al.  Coronary Adventitial and Perivascular Adipose Tissue Inflammation in Patients With Vasospastic Angina. , 2018, Journal of the American College of Cardiology.

[33]  G. Niccoli,et al.  Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests , 2017, European heart journal.

[34]  E. Prescott,et al.  Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries. , 2017, Journal of the American College of Cardiology.

[35]  P. Libby,et al.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.

[36]  H. Shimokawa,et al.  Endothelial dysfunction and vascular disease – a 30th anniversary update , 2017, Acta physiologica.

[37]  Kenta Ito,et al.  Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries , 2016, European heart journal.

[38]  Kenta Ito,et al.  Enhanced Adventitial Vasa Vasorum Formation in Patients With Vasospastic Angina: Assessment With OFDI. , 2016, Journal of the American College of Cardiology.

[39]  H. Shimokawa,et al.  RhoA/Rho-Kinase in the Cardiovascular System. , 2016, Circulation research.

[40]  H. Shimokawa,et al.  Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[41]  Gabriel A. Koepp,et al.  Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. , 2015, The New England journal of medicine.

[42]  R Jay Widmer,et al.  Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. , 2015, JACC. Cardiovascular interventions.

[43]  Ryotaro Yamada,et al.  Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease , 2015, Circulation.

[44]  S. Miyata,et al.  Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. , 2015, European heart journal.

[45]  H. Shimokawa 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside. , 2014, European heart journal.

[46]  Deepak L. Bhatt,et al.  Nonobstructive coronary artery disease and risk of myocardial infarction. , 2014, JAMA.

[47]  O. Rimoldi,et al.  Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes , 2014, Circulation.

[48]  F. Crea,et al.  Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .

[49]  J. Kaski,et al.  Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.

[50]  Filippo Crea,et al.  Coronary microvascular dysfunction. , 2013, The New England journal of medicine.

[51]  Carl J Pepine,et al.  Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. , 2013, American heart journal.

[52]  K. Sakamoto,et al.  Microvascular Coronary Artery Spasm Presents Distinctive Clinical Features With Endothelial Dysfunction as Nonobstructive Coronary Artery Disease , 2012, Journal of the American Heart Association.

[53]  Erik Jørgensen,et al.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.

[54]  J. Kaski,et al.  High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). , 2012, Journal of the American College of Cardiology.

[55]  Kenta Ito,et al.  Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment. , 2011, Journal of the American College of Cardiology.

[56]  Pamela S Douglas,et al.  Low diagnostic yield of elective coronary angiography. , 2010, The New England journal of medicine.

[57]  Kenta Ito,et al.  Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. , 2009, Journal of the American College of Cardiology.

[58]  Carl J Pepine,et al.  Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.

[59]  A. Maseri,et al.  Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[60]  H. Shimokawa,et al.  Myocardial ischemia: current concepts and future perspectives. , 2008, Journal of cardiology.

[61]  L. Shaw,et al.  Impact of Ethnicity and Gender Differences on Angiographic Coronary Artery Disease Prevalence and In-Hospital Mortality in the American College of Cardiology–National Cardiovascular Data Registry , 2008, Circulation.

[62]  Hidezo Mori,et al.  Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo. , 2007, Journal of the American College of Cardiology.

[63]  Hidezo Mori,et al.  Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo. , 2006, American journal of physiology. Heart and circulatory physiology.

[64]  Carl J Pepine,et al.  Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. , 2006, Journal of the American College of Cardiology.

[65]  K. Sunagawa,et al.  Coronary Microvascular Dysfunction in Patients With Microvascular Angina: Analysis by TIMI Frame Count , 2005, Journal of cardiovascular pharmacology.

[66]  H. Shimokawa,et al.  Usefulness of Fasudil, a Rho-kinase Inhibitor, to Treat Intractable Severe Coronary Spasm after Coronary Artery Bypass Surgery , 2004, Journal of cardiovascular pharmacology.

[67]  K. Smith,et al.  Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results From the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[68]  Yasuo Ogasawara,et al.  Hydrogen Peroxide, an Endogenous Endothelium-Derived Hyperpolarizing Factor, Plays an Important Role in Coronary Autoregulation In Vivo , 2003, Circulation.

[69]  Takashi Saito,et al.  Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles , 2003, Circulation research.

[70]  A. Takeshita,et al.  Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. , 2002, Journal of the American College of Cardiology.

[71]  A. Takeshita,et al.  Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. , 2001, International journal of cardiology.

[72]  H Shimokawa,et al.  Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. , 2000, The Journal of clinical investigation.

[73]  N Reichek,et al.  The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. , 1999, Journal of the American College of Cardiology.

[74]  A. Takeshita,et al.  Angina pectoris caused by coronary microvascular spasm , 1998, The Lancet.

[75]  A. Takeshita,et al.  Importance of endothelium-derived hyperpolarizing factor in human arteries. , 1997, The Journal of clinical investigation.

[76]  R Busse,et al.  Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. , 1996, Circulation.

[77]  M. Fujishima,et al.  The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. , 1996, Journal of cardiovascular pharmacology.

[78]  A. Takeshita,et al.  Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. , 1996, The Journal of clinical investigation.

[79]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[80]  F. Crea,et al.  Inappropriate Constriction of Small Coronary Vessels as a Possible Cause of a Positive Exercise Test Early After Successful Coronary Angioplasty , 1991, Circulation.

[81]  A. Maseri,et al.  Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. , 1991, The New England journal of medicine.

[82]  F. Crea,et al.  Mechanisms of angina pectoris in syndrome X. , 1991, Journal of the American College of Cardiology.

[83]  F. Crea,et al.  Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. , 1990, The New England journal of medicine.

[84]  A. Maseri,et al.  Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. , 1989, The American journal of cardiology.

[85]  H. Kennedy,et al.  Impaired coronary vasodilator reserve in the immediate postcoronary angioplasty period: analysis of coronary artery flow velocity indexes and regional cardiac venous efflux. , 1989, Journal of the American College of Cardiology.

[86]  R. Kerwin,et al.  CORONARY ARTERY INFUSION OF NEUROPEPTIDE Y IN PATIENTS WITH ANGINA PECTORIS , 1987, The Lancet.

[87]  A. Gallino,et al.  ROLE OF HEART RATE IN PATHOPHYSIOLOGY OF CHRONIC STABLE ANGINA , 1984, The Lancet.

[88]  S. Chierchia,et al.  MYOCARDIAL ISCHAEMIA DURING DAILY LIFE IN PATIENTS WITH STABLE ANGINA: ITS RELATION TO SYMPTOMS AND HEART RATE CHANGES , 1983, The Lancet.

[89]  K. Tanaka,et al.  Coronary artery spasm induced in atherosclerotic miniature swine. , 1983, Science.

[90]  A. Maseri THE CHANGING FACE OF ANGINA PECTORIS: PRACTICAL IMPLICATIONS , 1983, The Lancet.

[91]  S. Chierchia,et al.  Coronary artery spasm: demonstration, definition, diagnosis, and consequences. , 1982, Progress in cardiovascular diseases.

[92]  A. Maseri The revival of coronary spasm. , 1981, The American journal of medicine.

[93]  S. Chierchia,et al.  Coronary vasospasm in ischemic heart disease. , 1980, Chest.

[94]  A. Maseri,et al.  Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit. , 1979, British heart journal.

[95]  S. Chierchia,et al.  Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.

[96]  S. Chierchia,et al.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. , 1978, The American journal of cardiology.

[97]  S. Chierchia,et al.  Coronary artery spasm--diagnostic and therapeutic implications. , 1978, American heart journal.

[98]  A. Maseri,et al.  CORONARY VASOSPASM IN ANGINA PECTORIS , 1977, The Lancet.

[99]  A. Maseri Pathophysiologic studies of the pulmonary and coronary circulations in man. , 1976, The American journal of cardiology.

[100]  A. Maseri,et al.  Transient Transmural Reduction of Myocardial Blood Flow, Demonstrated by Thallium‐201 Scintigraphy, as a Cause of Variant Angina , 1976, Circulation.

[101]  C. Marchesi,et al.  Coronary Artery Spasm as a Cause of Acute Myocardial Ischemia in Man , 1975 .

[102]  N. Krasnow,et al.  Myocardial lactate and pyruvate metabolism. , 1962, The Journal of clinical investigation.

[103]  R. Daley The Autonomic Nervous System in its Relation to Some Forms of Heart and Lung Disease* , 1957 .

[104]  OUP accepted manuscript , 2022, Cardiovascular Research.

[105]  H. Shimokawa Coronary Vasomotion Abnormalities , 2021 .

[106]  Hiroaki Shimokawa,et al.  International standardization of diagnostic criteria for microvascular angina. , 2018, International journal of cardiology.

[107]  Ornella Rimoldi,et al.  Coronary microvascular dysfunction: mechanisms and functional assessment , 2015, Nature Reviews Cardiology.

[108]  Hiroaki Shimokawa,et al.  Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. , 2003, Journal of the American College of Cardiology.

[109]  A. Maseri,et al.  Endothelin‐1 Is a Potent Constrictor in Conductive and Resistive Coronary Arteries , 1989, Journal of cardiovascular pharmacology.